The Valley Desk

ReviewFuture oncology (London, England)Published

Achieving white blood cell equity: are the safety profiles of biosimilar and reference pegfilgrastims comparable?

Read the publication ↗ Open access copy ↗

Regional connection

Listed An author affiliation on the Europe PMC record names Capital Health. Affiliation source

Institution
Capital Health

Publication record

Type
Review
Venue
Future oncology (London, England)
Published
Subject terms
Leukocytes; Humans; Polyethylene Glycols; Filgrastim; Biosimilar Pharmaceuticals; Safety; Febrile Neutropenia; Adverse Event; Biosimilar; Biologic; Pegfilgrastim
PubMed ID
37609795
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal